Profile data is unavailable for this security.
About the company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
- Revenue in USD (TTM)8.10bn
- Net income in USD599.48m
- Incorporated1989
- Employees39.80k
- LocationICON PLCSouth County Business ParkLEOPARDSTOWN, Dublin 18DUBLIN 00000IrelandIRL
- Phone+353 12912000
- Fax+353 12912700
- Websitehttps://www.iconplc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc | 46.02m | -130.15m | 6.01bn | 132.00 | -- | 9.59 | -- | 130.68 | -2.04 | -2.04 | 0.7239 | 9.82 | 0.0651 | -- | 12.10 | 348,606.10 | -18.42 | -8.51 | -19.72 | -9.31 | -- | -- | -282.83 | -31.44 | -- | -- | 0.00 | -- | -89.41 | 9.96 | -147.29 | -- | 27.55 | -- |
| Cogent Biosciences Inc | 0.00 | -277.80m | 6.31bn | 258.00 | -- | 11.45 | -- | -- | -2.15 | -2.15 | 0.00 | 3.95 | 0.00 | -- | -- | 0.00 | -51.99 | -55.96 | -57.41 | -62.16 | -- | -- | -- | -- | -- | -- | 0.2594 | -- | -- | -- | -37.96 | -- | -- | -- |
| Belite Bio Inc (ADR) | 0.00 | -49.38m | 6.66bn | 25.00 | -- | -- | -- | -- | -1.55 | -1.55 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -36.85 | -- | -36.85 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -14.26 | -- | -- | -- |
| Arcellx Inc | 22.29m | -228.93m | 6.67bn | 209.00 | -- | 16.42 | -- | 299.27 | -4.06 | -4.06 | 0.3945 | 6.95 | 0.0339 | -- | 7.31 | 106,631.60 | -34.81 | -28.60 | -42.17 | -34.05 | -- | -- | -1,027.26 | -274.64 | -- | -- | 0.00 | -- | -79.35 | -- | -113.26 | -- | 21.25 | -- |
| Kymera Therapeutics Inc | 39.21m | -311.35m | 7.36bn | 238.00 | -- | 4.64 | -- | 187.60 | -3.68 | -3.68 | 0.4642 | 19.42 | 0.0288 | -- | -- | 164,747.90 | -22.89 | -24.17 | -24.23 | -27.06 | -- | -- | -794.06 | -329.38 | -- | -- | 0.0021 | -- | -16.70 | 2.87 | -39.08 | -- | -30.75 | -- |
| Cytokinetics, Inc. | 88.04m | -784.96m | 7.57bn | 673.00 | -- | -- | -- | 85.94 | -6.53 | -6.53 | 0.733 | -5.37 | 0.0623 | -- | 5.12 | 130,815.80 | -55.55 | -49.49 | -64.23 | -55.60 | -- | -- | -891.60 | -897.66 | -- | -11.95 | 2.33 | -- | 376.56 | 9.54 | -33.15 | -- | 17.55 | -- |
| Nuvalent Inc | 0.00 | -425.38m | 7.96bn | 228.00 | -- | 6.35 | -- | -- | -5.85 | -5.85 | 0.00 | 15.96 | 0.00 | -- | -- | 0.00 | -33.30 | -27.97 | -35.31 | -29.39 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -63.13 | -- | -- | -- |
| ICON PLC | 8.10bn | 599.48m | 8.27bn | 39.80k | 14.64 | 0.8857 | 8.37 | 1.02 | 7.40 | 7.40 | 101.04 | 122.25 | 0.4806 | -- | 3.00 | 193,379.50 | 3.56 | 3.70 | 4.33 | 4.46 | 28.15 | 29.00 | 7.40 | 7.41 | -- | 5.94 | 0.2675 | -- | 1.99 | 24.17 | 29.26 | 16.18 | 27.11 | -- |
| Charles River Lbrtrs ntrntl Inc | 4.02bn | -144.34m | 8.79bn | 18.30k | -- | 2.78 | 33.67 | 2.19 | -2.96 | -2.96 | 80.79 | 64.30 | 0.5477 | 9.04 | 5.62 | 219,419.80 | -1.94 | 3.42 | -2.28 | 4.01 | 34.98 | 36.22 | -3.54 | 6.37 | 1.02 | 3.43 | 0.3999 | 0.00 | -0.8545 | 6.55 | -1,501.75 | -- | 5.64 | -- |
| Vaxcyte Inc | 0.00 | -766.63m | 8.92bn | 507.00 | -- | 3.02 | -- | -- | -5.63 | -5.63 | 0.00 | 20.49 | 0.00 | -- | -- | 0.00 | -23.54 | -24.62 | -24.86 | -26.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -65.25 | -- | 118.08 | -- |
| Arrowhead Pharmaceuticals Inc | 1.09bn | 202.27m | 9.01bn | 711.00 | 41.75 | 15.55 | 34.82 | 8.26 | 1.54 | 1.54 | 7.90 | 4.14 | 0.8335 | -- | 9.86 | 1,534,432.00 | 17.84 | -25.96 | 21.44 | -30.82 | -- | -- | 21.41 | -76.01 | -- | 5.91 | 0.5068 | -- | 23,258.15 | 56.63 | 99.73 | -- | 13.66 | -- |
| BIO-TECHNE Corp | 1.22bn | 79.96m | 9.05bn | 3.10k | 113.92 | 4.48 | 49.24 | 7.44 | 0.5076 | 0.5076 | 7.74 | 12.90 | 0.4682 | 2.06 | 6.04 | 392,121.60 | 3.08 | 7.62 | 3.27 | 8.13 | 66.60 | 67.49 | 6.58 | 16.74 | 3.08 | 56.92 | 0.1145 | 26.72 | 5.23 | 10.55 | -56.35 | -20.37 | -9.74 | -4.36 |
| Praxis Precision Medicines Inc | 0.00 | -303.27m | 9.21bn | 168.00 | -- | 9.49 | -- | -- | -13.45 | -13.45 | 0.00 | 34.85 | 0.00 | -- | -- | 0.00 | -42.68 | -61.92 | -45.82 | -68.99 | -- | -- | -- | -9,004.13 | -- | -- | 0.00 | -- | -100.00 | -- | -65.88 | -- | -- | -- |
| Tempus AI Inc | 1.27bn | -245.03m | 9.53bn | 3.80k | -- | 19.34 | -- | 7.49 | -1.41 | -1.41 | 7.30 | 2.76 | 0.7946 | 10.52 | 5.46 | 334,681.30 | -15.31 | -41.14 | -19.31 | -55.06 | 62.74 | 54.59 | -19.27 | -55.73 | 3.00 | -3.90 | 0.7161 | -- | 83.41 | 46.57 | 67.17 | -- | 15.24 | -- |
| Madrigal Pharmaceuticals Inc | 958.40m | -288.28m | 9.99bn | 915.00 | -- | 16.51 | -- | 10.43 | -12.85 | -12.85 | 42.72 | 26.39 | 0.8327 | 1.03 | 10.18 | 1,047,435.00 | -25.05 | -53.85 | -31.64 | -68.43 | 94.14 | -- | -30.08 | -146.24 | 3.77 | -- | 0.3606 | -- | 432.05 | -- | 38.12 | -- | 59.68 | -- |
Data as of Mar 02 2026. Currency figures normalised to ICON PLC's reporting currency: US Dollar USD
42.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 31 Dec 2025 | 6.87m | 9.00% |
| Orbis Investment Management Ltd.as of 31 Dec 2025 | 4.21m | 5.52% |
| Wellington Management Co. LLPas of 31 Dec 2025 | 3.50m | 4.59% |
| Invesco Advisers, Inc.as of 31 Dec 2025 | 3.28m | 4.30% |
| Principal Global Investors LLCas of 31 Dec 2025 | 3.00m | 3.93% |
| Ninety One UK Ltd.as of 31 Dec 2025 | 2.95m | 3.86% |
| Harris Associates LPas of 31 Dec 2025 | 2.51m | 3.29% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 2.37m | 3.10% |
| Templeton Global Advisors Ltd.as of 31 Dec 2025 | 2.04m | 2.67% |
| Ruane, Cunniff & Goldfarb LPas of 31 Dec 2025 | 1.68m | 2.20% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
